← Back to news

Markets

Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire

Y

How Much Do You Really Need Invested To Replace A $60k Salary With Dividends? New PF Investment Income Series

Y

Anthony Scaramucci Says He Owns SpaceX Stock And Won't Miss Out On The IPO Despite Elon Musk's 'Cult Of Personality' Premium

Y

The Regulatory Case for XRP: Why Its Legal Status Changes Everything

Y

I Am Sharing Two Of My Retirement High-Yield Gems

S

Think It’s Too Late to Buy Ciena? Here’s the Case for Getting In Now

Y

A VP at Box Sold 24,500 Shares. Should Investors Avoid the Stock?

Y

I Asked ChatGPT the Best Way To Claim Social Security — Then Had a Retirement Planner Review It

Y

Rezolve AI (RZLV) Committed Towards 2026 Strategy Execution

Y

HIVE Digital (HIVE) Betting Big on AI Data Centers

Y

Aurora Innovation (AUR) is One of the Best Software Penny Stocks to Buy, Here is Why

Y

Her is What Makes Blend Labs (BLND) Appear so Attractive

Y

Why Yext (YEXT) Could be a Top Performing Software Penny Stock

Y

Telos Corp. (TLS) Showing Resistance Against Software Segment Hurdles

Y

Weave Communications (WEAV) Acknowledges Partnership With Minted Technology Advisors

Y

Rimini Street (RMNI) Enters Into a Multi-Year Partnership With South Korea’s Lotte Rental

Y

Nvidia-backed SiFive hits $3.65 billion valuation for open AI chips

Y

Bank of America sends frank message on next Fed rate cut

Y

How a Roth IRA Helps Your Social Security Benefits Go Further

Y

Why Self-Employed Dentists Are Replacing the SEP IRA With a Solo 401(k) and Saving Up to $23,000 More Per Year

Y

Ford Is Taking Lemons in the World's Largest Auto Market and Making Lemonade

Y

30% of Your Retirement Savings in One Company? Bad Idea, Says Wes Moore

Y

How bond market's private credit crisis fears are playing out in fixed-income ETFs

F

Better Vanguard Bond ETF: BND vs. VGIT

Y

2 Overvalued Consumer Stocks Investors Should Buy if a Massive Pullback Occurs

Y

Nvidia Just Posted Its Longest Winning Streak Since 2023. Is This Time for Real?

Y

Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors.

Y

Amazon vs. Walmart: The Retail War Just Picked a Winner

Y

Is It Too Late to Buy Tesla Stock?

Y

Meta Stock Needs to Show How Much Cash It Can Squeeze Out of Its New AI Tools before Q1; Barclays Reiterates Buy Forecast

Y

Palantir stock caught in a battle over pension billions

Y

Working While on Social Security? Here's a Key Rule Retirees Need to Know

Y

Anita Verma-Lallian's $1.5B Arizona Land Moves Put Her Next to Bill Gates' Smart City

Y

1 Reason to Buy and Hold Strategy Stock for the Next Decade

Y

QQQ Beat the Market 46% Last Year. Here’s the Volatility You’re Really Buying

Y

Better iShares Bond ETF: IEI vs. MUB

Y

Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley

Y

Morning Movers: Organon jumps after report of Sun Pharmaceutical bid

Y

Gilead price target raised to $175 from $171 at Morgan Stanley

Y

Why Monday, April 13 Begins A Critical Week For The Stock Market Rally

Y

United Therapeutics price target raised to $519 from $471 at Morgan Stanley

Y

What AI Fatigue? Anthropic's Red-Hot Growth Is Going to Supercharge These 3 AI Leaders.

Y

Biogen price target raised to $200 from $190 at Morgan Stanley

Y

I’m a Tax Preparer: The Refund Error That Triggers IRS Letters Most Often

Y

Here's What the Futures Markets Are Saying About Oil and the Conflict in the Persian Gulf

Y

Nike on the brink as shares crash 75% from highs. Critics say brand went ‘woke’ and is now broke (but here’s the truth)

Y

As the April 15 Deadline Approaches, the IRA Is One of the Most Overlooked Tax Breaks in Retirement Planning

Y

A $1 Million Portfolio That Quietly Pays You $67,500 a Year, No Job Required

Y

How Much Do You Really Need Invested to Replace a $60K Salary With Dividends?

Y

Potential $5,000 Monthly Income: 12 Investments To Buy And Hold For The Next 10 Years

S